Anthrax lethal factor cleaves regulatory subunits of phosphoinositide-3 kinase to contribute to toxin lethality
Anthrax lethal toxin (LT), produced by Bacillus anthracis , comprises a receptor-binding moiety, protective antigen and the lethal factor (LF) protease 1 , 2 . Although LF is known to cleave mitogen-activated protein kinase kinases (MEKs/MKKs) and some variants of the NLRP1 inflammasome sensor, targ...
Saved in:
Published in | Nature microbiology Vol. 5; no. 12; pp. 1464 - 1471 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
Nature Publishing Group UK
01.12.2020
Nature Publishing Group |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Anthrax lethal toxin (LT), produced by
Bacillus anthracis
, comprises a receptor-binding moiety, protective antigen and the lethal factor (LF) protease
1
,
2
. Although LF is known to cleave mitogen-activated protein kinase kinases (MEKs/MKKs) and some variants of the NLRP1 inflammasome sensor, targeting of these pathways does not explain the lethality of anthrax toxin
1
,
2
. Here we report that the regulatory subunits of phosphoinositide-3 kinase (PI3K)—p85α (PIK3R1) and p85β (PIK3R2)
3
,
4
—are substrates of LF. Cleavage of these proteins in a proline-rich region between their N-terminal Src homology and Bcr homology domains disrupts homodimer formation and impacts PI3K signalling. Mice carrying a mutated p85α that cannot be cleaved by LF show a greater resistance to anthrax toxin challenge. The LF(W271A) mutant cleaves p85α with lower efficiency and is non-toxic to mice but can regain lethality when combined with PI3K pathway inhibitors. We provide evidence that LF targets two signalling pathways that are essential for growth and metabolism and that the disabling of both pathways is likely necessary for lethal anthrax infection.
Cellular targets of anthrax lethal factor are identified to reveal the molecular basis of toxin-induced death. |
---|---|
AbstractList | Anthrax lethal toxin (LT), produced by Bacillus anthracis, comprises a receptor-binding moiety, protective antigen and the lethal factor (LF) protease1,2. Although LF is known to cleave mitogen-activated protein kinase kinases (MEKs/MKKs) and some variants of the NLRP1 inflammasome sensor, targeting of these pathways does not explain the lethality of anthrax toxin1,2. Here we report that the regulatory subunits of phosphoinositide-3 kinase (PI3K)-p85α (PIK3R1) and p85β (PIK3R2)3,4-are substrates of LF. Cleavage of these proteins in a proline-rich region between their N-terminal Src homology and Bcr homology domains disrupts homodimer formation and impacts PI3K signalling. Mice carrying a mutated p85α that cannot be cleaved by LF show a greater resistance to anthrax toxin challenge. The LF(W271A) mutant cleaves p85α with lower efficiency and is non-toxic to mice but can regain lethality when combined with PI3K pathway inhibitors. We provide evidence that LF targets two signalling pathways that are essential for growth and metabolism and that the disabling of both pathways is likely necessary for lethal anthrax infection.Anthrax lethal toxin (LT), produced by Bacillus anthracis, comprises a receptor-binding moiety, protective antigen and the lethal factor (LF) protease1,2. Although LF is known to cleave mitogen-activated protein kinase kinases (MEKs/MKKs) and some variants of the NLRP1 inflammasome sensor, targeting of these pathways does not explain the lethality of anthrax toxin1,2. Here we report that the regulatory subunits of phosphoinositide-3 kinase (PI3K)-p85α (PIK3R1) and p85β (PIK3R2)3,4-are substrates of LF. Cleavage of these proteins in a proline-rich region between their N-terminal Src homology and Bcr homology domains disrupts homodimer formation and impacts PI3K signalling. Mice carrying a mutated p85α that cannot be cleaved by LF show a greater resistance to anthrax toxin challenge. The LF(W271A) mutant cleaves p85α with lower efficiency and is non-toxic to mice but can regain lethality when combined with PI3K pathway inhibitors. We provide evidence that LF targets two signalling pathways that are essential for growth and metabolism and that the disabling of both pathways is likely necessary for lethal anthrax infection. Anthrax lethal toxin (LT), produced by Bacillus anthracis, comprises a receptor-binding moiety, protective antigen and the lethal factor (LF) protease1,2. Although LF is known to cleave mitogen-activated protein kinase kinases (MEKs/MKKs) and some variants of the NLRP1 inflammasome sensor, targeting of these pathways does not explain the lethality of anthrax toxin1,2. Here we report that the regulatory subunits of phosphoinositide-3 kinase (PI3K)—p85α (PIK3R1) and p85β (PIK3R2)3,4—are substrates of LF. Cleavage of these proteins in a proline-rich region between their N-terminal Src homology and Bcr homology domains disrupts homodimer formation and impacts PI3K signalling. Mice carrying a mutated p85α that cannot be cleaved by LF show a greater resistance to anthrax toxin challenge. The LF(W271A) mutant cleaves p85α with lower efficiency and is non-toxic to mice but can regain lethality when combined with PI3K pathway inhibitors. We provide evidence that LF targets two signalling pathways that are essential for growth and metabolism and that the disabling of both pathways is likely necessary for lethal anthrax infection.Cellular targets of anthrax lethal factor are identified to reveal the molecular basis of toxin-induced death. Anthrax lethal toxin (LT), produced by Bacillus anthracis , comprises a receptor-binding moiety, protective antigen and the lethal factor (LF) protease 1 , 2 . Although LF is known to cleave mitogen-activated protein kinase kinases (MEKs/MKKs) and some variants of the NLRP1 inflammasome sensor, targeting of these pathways does not explain the lethality of anthrax toxin 1 , 2 . Here we report that the regulatory subunits of phosphoinositide-3 kinase (PI3K)—p85α (PIK3R1) and p85β (PIK3R2) 3 , 4 —are substrates of LF. Cleavage of these proteins in a proline-rich region between their N-terminal Src homology and Bcr homology domains disrupts homodimer formation and impacts PI3K signalling. Mice carrying a mutated p85α that cannot be cleaved by LF show a greater resistance to anthrax toxin challenge. The LF(W271A) mutant cleaves p85α with lower efficiency and is non-toxic to mice but can regain lethality when combined with PI3K pathway inhibitors. We provide evidence that LF targets two signalling pathways that are essential for growth and metabolism and that the disabling of both pathways is likely necessary for lethal anthrax infection. Cellular targets of anthrax lethal factor are identified to reveal the molecular basis of toxin-induced death. Anthrax lethal toxin (LT), produced by Bacillus anthracis , comprises a receptor-binding moiety, protective antigen and the lethal factor (LF) protease 1 , 2 . Although LF is known to cleave mitogen-activated protein kinase kinases (MEKs/MKKs) and some variants of the NLRP1 inflammasome sensor, targeting of these pathways does not explain the lethality of anthrax toxin 1 , 2 . Here we report that the regulatory subunits of phosphoinositide-3 kinase (PI3K)—p85α (PIK3R1) and p85β (PIK3R2) 3 , 4 —are substrates of LF. Cleavage of these proteins in a proline-rich region between their N-terminal Src homology and Bcr homology domains disrupts homodimer formation and impacts PI3K signalling. Mice carrying a mutated p85α that cannot be cleaved by LF show a greater resistance to anthrax toxin challenge. The LF(W271A) mutant cleaves p85α with lower efficiency and is non-toxic to mice but can regain lethality when combined with PI3K pathway inhibitors. We provide evidence that LF targets two signalling pathways that are essential for growth and metabolism and that the disabling of both pathways is likely necessary for lethal anthrax infection. Anthrax lethal toxin (LT), produced by Bacillus anthracis, comprises a receptor-binding moiety, protective antigen and the lethal factor (LF) protease . Although LF is known to cleave mitogen-activated protein kinase kinases (MEKs/MKKs) and some variants of the NLRP1 inflammasome sensor, targeting of these pathways does not explain the lethality of anthrax toxin . Here we report that the regulatory subunits of phosphoinositide-3 kinase (PI3K)-p85α (PIK3R1) and p85β (PIK3R2) -are substrates of LF. Cleavage of these proteins in a proline-rich region between their N-terminal Src homology and Bcr homology domains disrupts homodimer formation and impacts PI3K signalling. Mice carrying a mutated p85α that cannot be cleaved by LF show a greater resistance to anthrax toxin challenge. The LF(W271A) mutant cleaves p85α with lower efficiency and is non-toxic to mice but can regain lethality when combined with PI3K pathway inhibitors. We provide evidence that LF targets two signalling pathways that are essential for growth and metabolism and that the disabling of both pathways is likely necessary for lethal anthrax infection. |
Author | Portley, Makayla K. Szabo, Roman Fattah, Rasem Khillan, Jaspal S. Liu, Shihui O’Mard, Danielle Leppla, Stephen H. Moayeri, Mahtab Bugge, Thomas H. Mendenhall, Megan A. |
AuthorAffiliation | 4 Mouse Genetics and Gene Modification Section, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA 1 Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA 2 Department of Medicine, Division of Infectious Diseases, University of Pittsburgh, Pittsburgh, PA, USA 3 Proteases and Tissue Remodeling Section, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, USA |
AuthorAffiliation_xml | – name: 2 Department of Medicine, Division of Infectious Diseases, University of Pittsburgh, Pittsburgh, PA, USA – name: 3 Proteases and Tissue Remodeling Section, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, USA – name: 1 Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA – name: 4 Mouse Genetics and Gene Modification Section, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA |
Author_xml | – sequence: 1 givenname: Megan A. orcidid: 0000-0003-1831-5839 surname: Mendenhall fullname: Mendenhall, Megan A. organization: Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health – sequence: 2 givenname: Shihui orcidid: 0000-0003-3444-1069 surname: Liu fullname: Liu, Shihui organization: Department of Medicine, Division of Infectious Diseases, University of Pittsburgh – sequence: 3 givenname: Makayla K. surname: Portley fullname: Portley, Makayla K. organization: Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health – sequence: 4 givenname: Danielle surname: O’Mard fullname: O’Mard, Danielle organization: Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health – sequence: 5 givenname: Rasem surname: Fattah fullname: Fattah, Rasem organization: Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health – sequence: 6 givenname: Roman surname: Szabo fullname: Szabo, Roman organization: Proteases and Tissue Remodeling Section, National Institute of Dental and Craniofacial Research, National Institutes of Health – sequence: 7 givenname: Thomas H. surname: Bugge fullname: Bugge, Thomas H. organization: Proteases and Tissue Remodeling Section, National Institute of Dental and Craniofacial Research, National Institutes of Health – sequence: 8 givenname: Jaspal S. surname: Khillan fullname: Khillan, Jaspal S. organization: Mouse Genetics and Gene Modification Section, National Institute of Allergy and Infectious Diseases, National Institutes of Health – sequence: 9 givenname: Stephen H. surname: Leppla fullname: Leppla, Stephen H. organization: Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health – sequence: 10 givenname: Mahtab orcidid: 0000-0002-4448-8883 surname: Moayeri fullname: Moayeri, Mahtab email: mmoayeri@niaid.nih.gov organization: Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/32895527$$D View this record in MEDLINE/PubMed |
BookMark | eNp1UU1v1DAQtVARLaU_gAuyxIVLYGzHTnJCVcWXVIkLnC3bmey6ZO3Fdqruv6-XXUpB4mDZ4_fmzRu95-QkxICEvGTwloHo3-WWSdU2wKGBrucNe0LOOMi-kbxTJ4_ep-Qi5xsAYIor1atn5FTwfpAVOyPxMpR1Mnd0xrI2M52MKzFRN6O5xUwTrpbZ1J8dzYtdgi-Zxolu1zHX40PMvvgRG0F_-GAy0hKpi6Ekb5fyqyrxzoejui-7F-TpZOaMF8f7nHz_-OHb1efm-uunL1eX141reV8a1k1c4jQhH62zFgYwCgUXIyJa6JzA3jDLwHaIExcCpBgZN2jNKIZBDeKcvD_obhe7wdFh9WRmvU1-Y9JOR-P130jwa72Kt5ox2QIoURXeHBVS_LlgLnrjs8N5NgHjkjVv22pLtsN-2Ot_qDdxSaHuV1mdBMl6ySuLHVguxZwTTg9uGOh9pPoQqa6R6n2kmtWeV4_XeOj4HWAl8AMhVyisMP0Z_X_Ve-ywsXs |
CitedBy_id | crossref_primary_10_1128_mbio_00037_24 crossref_primary_10_1016_j_chembiol_2024_03_009 crossref_primary_10_1038_s41593_021_00973_8 crossref_primary_10_3390_toxins15090528 crossref_primary_10_1016_j_mam_2022_101143 crossref_primary_10_2139_ssrn_4168545 crossref_primary_10_1016_j_bios_2022_114800 crossref_primary_10_1016_j_vaccine_2022_06_023 crossref_primary_10_1016_j_jbc_2021_101467 |
Cites_doi | 10.1038/nprot.2010.5 10.1096/fj.201700672RR 10.1016/j.ejcb.2010.11.008 10.1074/jbc.M113.530006 10.1042/bj3360241 10.1073/pnas.0908899107 10.1074/jbc.M200732200 10.1073/pnas.012581799 10.1042/bj3520739 10.18632/oncotarget.19866 10.2217/pgs.15.174 10.1007/5584_2018_273 10.1128/IAI.73.12.8275-8281.2005 10.1021/bi0205911 10.1007/s10549-019-05320-x 10.1146/annurev-micro-091014-104523 10.1074/jbc.M211262200 10.1006/bbrc.1998.9040 10.1042/BJ20111164 10.1074/jbc.274.18.12323 10.1371/journal.pone.0049741 10.1006/prep.2000.1208 10.1074/jbc.M117.805648 10.1038/onc.2011.164 10.1038/81715 10.1073/pnas.1009652107 10.1038/nsmb708 10.4049/jimmunol.180.6.4218 10.1126/science.283.5400.393 10.1073/pnas.0902369106 10.1016/j.tim.2014.02.012 10.1074/jbc.M111.323709 10.1074/jbc.M116.761734 10.1371/journal.ppat.1002638 10.1016/j.ccr.2009.10.016 10.7554/eLife.06866 10.1074/jbc.M009698200 10.1002/0471250953.bi0508s52 10.1016/j.cell.2017.04.001 10.1016/j.jbior.2019.100657 10.1126/stke.3622006pe49 10.1158/0008-5472.CAN-11-3747 10.1073/pnas.0604628103 10.1126/science.280.5364.734 10.3390/toxins8070197 10.1172/JCI0213305 |
ContentType | Journal Article |
Copyright | The Author(s), under exclusive licence to Springer Nature Limited 2020 The Author(s), under exclusive licence to Springer Nature Limited 2020. |
Copyright_xml | – notice: The Author(s), under exclusive licence to Springer Nature Limited 2020 – notice: The Author(s), under exclusive licence to Springer Nature Limited 2020. |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 8FE 8FH AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO GNUQQ HCIFZ LK8 M7P PQEST PQQKQ PQUKI PRINS 7X8 5PM |
DOI | 10.1038/s41564-020-0782-1 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef ProQuest SciTech Collection ProQuest Natural Science Collection ProQuest Central ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One Community College ProQuest Central Korea ProQuest Central Student SciTech Premium Collection Biological Sciences Biological Science Database ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef ProQuest Central Student ProQuest Biological Science Collection ProQuest Central Essentials ProQuest One Academic Eastern Edition SciTech Premium Collection ProQuest One Community College ProQuest Natural Science Collection Biological Science Database ProQuest SciTech Collection ProQuest Central China ProQuest Central ProQuest One Academic UKI Edition Natural Science Collection ProQuest Central Korea Biological Science Collection ProQuest One Academic MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic ProQuest Central Student MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 2058-5276 |
EndPage | 1471 |
ExternalDocumentID | 10_1038_s41564_020_0782_1 32895527 |
Genre | Journal Article Research Support, N.I.H., Intramural |
GrantInformation_xml | – fundername: U.S. Department of Health & Human Services | National Institutes of Health (NIH) grantid: 1 ZIA AI001032; 1 ZIA AI001032 funderid: https://doi.org/10.13039/100000002 – fundername: Intramural NIH HHS grantid: Z01 AI001032 – fundername: Intramural NIH HHS grantid: ZIA AI001032 |
GroupedDBID | 0R~ 53G 8FE 8FH AAEEF AAHBH AARCD AAZLF ABLJU ABVXF ACGFS ADBBV AFBBN AFKRA AFSHS AFWHJ AHSBF AIBTJ ALFFA ALMA_UNASSIGNED_HOLDINGS ARMCB AXYYD BBNVY BENPR BHPHI BKKNO CCPQU EBS EJD FSGXE FZEXT HCIFZ HZ~ LK8 M7P NNMJJ O9- ODYON R9- RNT SHXYY SIXXV SNYQT TAOOD TBHMF TDRGL TSG AAYZH ACBWK CGR CUY CVF ECM EIF NPM AAYXX CITATION AZQEC DWQXO GNUQQ PQEST PQQKQ PQUKI PRINS 7X8 5PM |
ID | FETCH-LOGICAL-c428t-17f25effe2dbcbb090a6e323deeeb07c3e8a1b10b7eef233053d12aebad399693 |
IEDL.DBID | BENPR |
ISSN | 2058-5276 |
IngestDate | Thu Nov 07 05:33:53 EST 2024 Thu Dec 05 20:16:24 EST 2024 Tue Nov 19 05:06:39 EST 2024 Thu Nov 21 22:52:52 EST 2024 Thu Nov 28 21:18:10 EST 2024 Fri Oct 11 20:46:49 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 12 |
Language | English |
License | Reprints and permissions information is available at www.nature.com/reprints. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c428t-17f25effe2dbcbb090a6e323deeeb07c3e8a1b10b7eef233053d12aebad399693 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 M.M. conceived the project. M.M. and M.A.M. designed and performed experiments and analysed the data. M.K.P. and D.O. performed experiments. S.L. designed experiments, performed preliminary mutant LF studies and analysed the data. S.H.L. designed constructs, contributed reagents and analysed the data. R.F. purified proteins and performed mass spectrometry analyses. R.S., T.H.B. and J.S.K. designed and created the knockin mouse model. M.M., M.A.M. and S.H.L. wrote and edited the manuscript with input from all authors. Author contributions |
ORCID | 0000-0003-1831-5839 0000-0003-3444-1069 0000-0002-4448-8883 |
PMID | 32895527 |
PQID | 2475051852 |
PQPubID | 2069616 |
PageCount | 8 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_11540063 proquest_miscellaneous_2440905499 proquest_journals_2475051852 crossref_primary_10_1038_s41564_020_0782_1 pubmed_primary_32895527 springer_journals_10_1038_s41564_020_0782_1 |
PublicationCentury | 2000 |
PublicationDate | 2020-12-01 |
PublicationDateYYYYMMDD | 2020-12-01 |
PublicationDate_xml | – month: 12 year: 2020 text: 2020-12-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | London |
PublicationPlace_xml | – name: London – name: England |
PublicationTitle | Nature microbiology |
PublicationTitleAbbrev | Nat Microbiol |
PublicationTitleAlternate | Nat Microbiol |
PublicationYear | 2020 |
Publisher | Nature Publishing Group UK Nature Publishing Group |
Publisher_xml | – name: Nature Publishing Group UK – name: Nature Publishing Group |
References | Ito, Vogt, Hart (CR30) 2017; 8 Ueki (CR37) 2002; 99 Park, Leppla (CR48) 2000; 18 Zhang (CR12) 2008; 9 Goldberg, Cho, Miller, Lou, Turk (CR15) 2017; 292 Ouyang, Guo, Fang, Frucht (CR18) 2017; 292 Bachran, Leppla (CR41) 2016; 8 Cheung, Mills (CR43) 2016; 17 Jaiswal (CR44) 2009; 16 Harpur (CR13) 1999; 274 Gratton (CR20) 2001; 276 Vitale (CR38) 1998; 248 Lu (CR27) 2011; 30 Yang, Zhang (CR10) 2015; 52 Yu, Liu, Cantley (CR26) 2002; 277 Gutierrez-Uzquiza, Arechederra, Bragado, Aguirre-Ghiso, Porras (CR21) 2012; 287 Wang (CR25) 2018; 32 Fruman (CR34) 2000; 26 Fruman (CR35) 1999; 283 Ouyang, Torigoe, Fang, Xie, Frucht (CR17) 2014; 289 Qin, Chock (CR29) 2003; 42 Duesbery (CR39) 1998; 280 Manning, Toker (CR23) 2017; 169 Turturro (CR47) 2019; 177 Liu, Moayeri, Leppla (CR1) 2014; 22 Moayeri, Leppla, Vrentas, Pomerantsev, Liu (CR2) 2015; 69 Levinsohn (CR6) 2012; 8 Chagpar (CR32) 2010; 107 Chopra, Boone, Liang, Duesbery (CR8) 2003; 278 Mellor, Furber, Nyarko, Anderson (CR3) 2012; 441 Shaw, Cohen, Alessi (CR28) 1998; 336 Wu (CR45) 2009; 106 Haeusgen, Herdegen, Waetzig (CR19) 2011; 90 Taniguchi (CR31) 2006; 103 Sun, Hillmann, Hofmann, Hart, Vogt (CR46) 2010; 107 Barber, Alvarado-Kristensson, Gonzalez-Garcia, Pulido, Carrera (CR33) 2006; 2006 Vitale, Bernardi, Napolitani, Mock, Montecucco (CR7) 2000; 352 Mauvais-Jarvis (CR36) 2002; 109 Liu (CR42) 2016; 113 Cheung (CR14) 2015; 4 Hellmich (CR40) 2012; 7 Roy, Kucukural, Zhang (CR11) 2010; 5 Luyendyk (CR22) 2008; 180 Rathinaswamy, Burke (CR4) 2020; 75 Comer, Chopra, Peterson, Konig (CR16) 2005; 73 Turk (CR5) 2019; 1111 Turk (CR9) 2004; 11 Turke (CR24) 2012; 72 J Yang (782_CR10) 2015; 52 W Ouyang (782_CR17) 2014; 289 C Bachran (782_CR41) 2016; 8 A Gutierrez-Uzquiza (782_CR21) 2012; 287 MK Rathinaswamy (782_CR4) 2020; 75 W Ouyang (782_CR18) 2017; 292 S Park (782_CR48) 2000; 18 AB Turke (782_CR24) 2012; 72 CF Yu (782_CR26) 2002; 277 AG Harpur (782_CR13) 1999; 274 LW Cheung (782_CR43) 2016; 17 JP Gratton (782_CR20) 2001; 276 M Shaw (782_CR28) 1998; 336 JP Luyendyk (782_CR22) 2008; 180 CM Taniguchi (782_CR31) 2006; 103 W Haeusgen (782_CR19) 2011; 90 KA Hellmich (782_CR40) 2012; 7 BE Turk (782_CR9) 2004; 11 S Qin (782_CR29) 2003; 42 K Ueki (782_CR37) 2002; 99 S Liu (782_CR42) 2016; 113 AP Chopra (782_CR8) 2003; 278 JL Levinsohn (782_CR6) 2012; 8 P Mellor (782_CR3) 2012; 441 DA Fruman (782_CR35) 1999; 283 AB Goldberg (782_CR15) 2017; 292 H Wu (782_CR45) 2009; 106 JE Comer (782_CR16) 2005; 73 L Wang (782_CR25) 2018; 32 M Moayeri (782_CR2) 2015; 69 F Mauvais-Jarvis (782_CR36) 2002; 109 LW Cheung (782_CR14) 2015; 4 Y Ito (782_CR30) 2017; 8 Y Lu (782_CR27) 2011; 30 A Roy (782_CR11) 2010; 5 DA Fruman (782_CR34) 2000; 26 DF Barber (782_CR33) 2006; 2006 G Vitale (782_CR38) 1998; 248 Y Zhang (782_CR12) 2008; 9 SB Turturro (782_CR47) 2019; 177 NS Duesbery (782_CR39) 1998; 280 BD Manning (782_CR23) 2017; 169 BS Jaiswal (782_CR44) 2009; 16 S Liu (782_CR1) 2014; 22 BE Turk (782_CR5) 2019; 1111 RB Chagpar (782_CR32) 2010; 107 G Vitale (782_CR7) 2000; 352 M Sun (782_CR46) 2010; 107 |
References_xml | – volume: 52 start-page: 5.8.1 year: 2015 end-page: 5.8.15 ident: CR10 article-title: Protein structure and function prediction using I-TASSER. publication-title: Curr. Protoc. Bioinformatics contributor: fullname: Zhang – volume: 69 start-page: 185 year: 2015 end-page: 208 ident: CR2 article-title: Anthrax pathogenesis publication-title: Annu. Rev. Microbiol. contributor: fullname: Liu – volume: 109 start-page: 141 year: 2002 end-page: 149 ident: CR36 article-title: Reduced expression of the murine p85α subunit of phosphoinositide 3-kinase improves insulin signaling and ameliorates diabetes publication-title: J. Clin. Invest. contributor: fullname: Mauvais-Jarvis – volume: 289 start-page: 4180 year: 2014 end-page: 4190 ident: CR17 article-title: Anthrax lethal toxin inhibits translation of hypoxia-inducible factor 1α and causes decreased tolerance to hypoxic stress publication-title: J. Biol. Chem. contributor: fullname: Frucht – volume: 17 start-page: 297 year: 2016 end-page: 307 ident: CR43 article-title: Targeting therapeutic liabilities engendered by mutations for cancer treatment publication-title: Pharmacogenomics contributor: fullname: Mills – volume: 22 start-page: 317 year: 2014 end-page: 325 ident: CR1 article-title: Anthrax lethal and edema toxins in anthrax pathogenesis publication-title: Trends Microbiol. contributor: fullname: Leppla – volume: 277 start-page: 19382 year: 2002 end-page: 19388 ident: CR26 article-title: ERK negatively regulates the epidermal growth factor-mediated interaction of Gab1 and the phosphatidylinositol 3-kinase publication-title: J. Biol. Chem. contributor: fullname: Cantley – volume: 99 start-page: 419 year: 2002 end-page: 424 ident: CR37 article-title: Increased insulin sensitivity in mice lacking p85β subunit of phosphoinositide 3-kinase publication-title: Proc. Natl Acad. Sci. USA contributor: fullname: Ueki – volume: 16 start-page: 463 year: 2009 end-page: 474 ident: CR44 article-title: Somatic mutations in p85α promote tumorigenesis through class IA PI3K activation publication-title: Cancer Cell contributor: fullname: Jaiswal – volume: 280 start-page: 734 year: 1998 end-page: 737 ident: CR39 article-title: Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor publication-title: Science contributor: fullname: Duesbery – volume: 72 start-page: 3228 year: 2012 end-page: 3237 ident: CR24 article-title: MEK inhibition leads to PI3K/AKT activation by relieving a negative feedback on ERBB receptors publication-title: Cancer Res. contributor: fullname: Turke – volume: 107 start-page: 15547 year: 2010 end-page: 15552 ident: CR46 article-title: Cancer-derived mutations in the regulatory subunit p85α of phosphoinositide 3-kinase function through the catalytic subunit p110α publication-title: Proc. Natl Acad. Sci. USA contributor: fullname: Vogt – volume: 8 start-page: e1002638 year: 2012 ident: CR6 article-title: Anthrax lethal factor cleavage of Nlrp1 is required for activation of the inflammasome publication-title: PLoS Pathog. contributor: fullname: Levinsohn – volume: 287 start-page: 2632 year: 2012 end-page: 2642 ident: CR21 article-title: p38α mediates cell survival in response to oxidative stress via induction of antioxidant genes: effect on the p70S6K pathway publication-title: J. Biol. Chem. contributor: fullname: Porras – volume: 4 start-page: e06866 year: 2015 ident: CR14 article-title: Regulation of the PI3K pathway through a p85α monomer–homodimer equilibrium. publication-title: eLife contributor: fullname: Cheung – volume: 106 start-page: 20258 year: 2009 end-page: 20263 ident: CR45 article-title: Regulation of class IA PI 3-kinases: C2 domain–iSH2 domain contacts inhibit p85/p110α and are disrupted in oncogenic p85 mutants publication-title: Proc. Natl Acad. Sci. USA contributor: fullname: Wu – volume: 248 start-page: 706 year: 1998 end-page: 711 ident: CR38 article-title: Anthrax lethal factor cleaves the N-terminus of MAPKKs and induces tyrosine/threonine phosphorylation of MAPKs in cultured macrophages publication-title: Biochem. Biophys. Res. Commun. contributor: fullname: Vitale – volume: 8 start-page: 197 year: 2016 ident: CR41 article-title: Tumor targeting and drug delivery by anthrax toxin publication-title: Toxins contributor: fullname: Leppla – volume: 292 start-page: 814 year: 2017 end-page: 825 ident: CR15 article-title: Identification of a substrate-selective exosite within the metalloproteinase anthrax lethal factor publication-title: J. Biol. Chem. contributor: fullname: Turk – volume: 441 start-page: 23 year: 2012 end-page: 37 ident: CR3 article-title: Multiple roles for the p85α isoform in the regulation and function of PI3K signalling and receptor trafficking publication-title: Biochem J. contributor: fullname: Anderson – volume: 42 start-page: 2995 year: 2003 end-page: 3003 ident: CR29 article-title: Implication of phosphatidylinositol 3-kinase membrane recruitment in hydrogen peroxide-induced activation of PI3K and Akt publication-title: Biochemistry contributor: fullname: Chock – volume: 7 start-page: e49741 year: 2012 ident: CR40 article-title: Anthrax lethal factor cleaves mouse Nlrp1b in both toxin-sensitive and toxin-resistant macrophages publication-title: PLoS ONE contributor: fullname: Hellmich – volume: 73 start-page: 8275 year: 2005 end-page: 8281 ident: CR16 article-title: Direct inhibition of T-lymphocyte activation by anthrax toxins in vivo publication-title: Infect. Immun. contributor: fullname: Konig – volume: 292 start-page: 17919 year: 2017 end-page: 17927 ident: CR18 article-title: Anthrax lethal toxin rapidly reduces c-Jun levels by inhibiting c-Jun gene transcription and promoting c-Jun protein degradation publication-title: J. Biol. Chem. contributor: fullname: Frucht – volume: 169 start-page: 381 year: 2017 end-page: 405 ident: CR23 article-title: AKT/PKB Signaling: navigating the network publication-title: Cell contributor: fullname: Toker – volume: 2006 start-page: pe49 year: 2006 ident: CR33 article-title: PTEN regulation, a novel function for the p85 subunit of phosphoinositide 3-kinase publication-title: Sci. STKE contributor: fullname: Carrera – volume: 1111 start-page: 189 year: 2019 end-page: 203 ident: CR5 article-title: Exceptionally selective substrate targeting by the metalloprotease anthrax lethal factor publication-title: Adv. Exp. Med. Biol. contributor: fullname: Turk – volume: 283 start-page: 393 year: 1999 end-page: 397 ident: CR35 article-title: Impaired B cell development and proliferation in absence of phosphoinositide 3-kinase p85α publication-title: Science contributor: fullname: Fruman – volume: 276 start-page: 30359 year: 2001 end-page: 30365 ident: CR20 article-title: Akt down-regulation of p38 signaling provides a novel mechanism of vascular endothelial growth factor-mediated cytoprotection in endothelial cells publication-title: J. Biol. Chem. contributor: fullname: Gratton – volume: 274 start-page: 12323 year: 1999 end-page: 12332 ident: CR13 article-title: Intermolecular interactions of the p85α regulatory subunit of phosphatidylinositol 3-kinase publication-title: J. Biol. Chem. contributor: fullname: Harpur – volume: 103 start-page: 12093 year: 2006 end-page: 12097 ident: CR31 article-title: Phosphoinositide 3-kinase regulatory subunit p85α suppresses insulin action via positive regulation of PTEN publication-title: Proc. Natl Acad. Sci. USA contributor: fullname: Taniguchi – volume: 32 start-page: 875 year: 2018 end-page: 887 ident: CR25 article-title: A ERK/RSK-mediated negative feedback loop regulates M-CSF-evoked PI3K/AKT activation in macrophages publication-title: FASEB J. contributor: fullname: Wang – volume: 30 start-page: 4567 year: 2011 end-page: 4577 ident: CR27 article-title: Kinome siRNA-phosphoproteomic screen identifies networks regulating AKT signaling publication-title: Oncogene contributor: fullname: Lu – volume: 8 start-page: 55863 year: 2017 end-page: 55876 ident: CR30 article-title: Domain analysis reveals striking functional differences between the regulatory subunits of phosphatidylinositol 3-kinase (PI3K), p85α and p85β publication-title: Oncotarget contributor: fullname: Hart – volume: 113 start-page: E4079 year: 2016 end-page: E4087 ident: CR42 article-title: Solid tumor therapy by selectively targeting stromal endothelial cells publication-title: Proc. Natl Acad. Sci. USA contributor: fullname: Liu – volume: 177 start-page: 325 year: 2019 end-page: 333 ident: CR47 article-title: Somatic loss of may sensitize breast cancer to inhibitors of the MAPK pathway publication-title: Breast Cancer Res. Treat. contributor: fullname: Turturro – volume: 352 start-page: 739 issue: Pt 3 year: 2000 end-page: 745 ident: CR7 article-title: Susceptibility of mitogen-activated protein kinase kinase family members to proteolysis by anthrax lethal factor publication-title: Biochem. J. contributor: fullname: Montecucco – volume: 9 year: 2008 ident: CR12 article-title: I-TASSER server for protein 3D structure prediction publication-title: BMC Bioinformatics contributor: fullname: Zhang – volume: 180 start-page: 4218 year: 2008 end-page: 4226 ident: CR22 article-title: Genetic analysis of the role of the PI3K–Akt pathway in lipopolysaccharide-induced cytokine and tissue factor gene expression in monocytes/macrophages publication-title: J. Immunol. contributor: fullname: Luyendyk – volume: 11 start-page: 60 year: 2004 end-page: 66 ident: CR9 article-title: The structural basis for substrate and inhibitor selectivity of the anthrax lethal factor publication-title: Nat. Struct. Mol. Biol. contributor: fullname: Turk – volume: 5 start-page: 725 year: 2010 end-page: 738 ident: CR11 article-title: I-TASSER: a unified platform for automated protein structure and function prediction publication-title: Nat. Protoc. contributor: fullname: Zhang – volume: 278 start-page: 9402 year: 2003 end-page: 9406 ident: CR8 article-title: Anthrax lethal factor proteolysis and inactivation of MAPK kinase publication-title: J. Biol. Chem. contributor: fullname: Duesbery – volume: 107 start-page: 5471 year: 2010 end-page: 5476 ident: CR32 article-title: Direct positive regulation of PTEN by the p85 subunit of phosphatidylinositol 3-kinase publication-title: Proc. Natl Acad. Sci. USA contributor: fullname: Chagpar – volume: 18 start-page: 293 year: 2000 end-page: 302 ident: CR48 article-title: Optimized production and purification of lethal factor publication-title: Protein Expr. Purif. contributor: fullname: Leppla – volume: 90 start-page: 536 year: 2011 end-page: 544 ident: CR19 article-title: The bottleneck of JNK signaling: molecular and functional characteristics of MKK4 and MKK7 publication-title: Eur. J. Cell Biol. contributor: fullname: Waetzig – volume: 75 start-page: 100657 year: 2020 ident: CR4 article-title: Class I phosphoinositide 3-kinase (PI3K) regulatory subunits and their roles in signaling and disease publication-title: Adv. Biol. Regul. contributor: fullname: Burke – volume: 336 start-page: 241 issue: Pt 1 year: 1998 end-page: 246 ident: CR28 article-title: The activation of protein kinase B by H O or heat shock is mediated by phosphoinositide 3-kinase and not by mitogen-activated protein kinase-activated protein kinase-2 publication-title: Biochem. J contributor: fullname: Alessi – volume: 26 start-page: 379 year: 2000 end-page: 382 ident: CR34 article-title: Hypoglycaemia, liver necrosis and perinatal death in mice lacking all isoforms of phosphoinositide 3-kinase p85α publication-title: Nat. Genet. contributor: fullname: Fruman – volume: 5 start-page: 725 year: 2010 ident: 782_CR11 publication-title: Nat. Protoc. doi: 10.1038/nprot.2010.5 contributor: fullname: A Roy – volume: 32 start-page: 875 year: 2018 ident: 782_CR25 publication-title: FASEB J. doi: 10.1096/fj.201700672RR contributor: fullname: L Wang – volume: 90 start-page: 536 year: 2011 ident: 782_CR19 publication-title: Eur. J. Cell Biol. doi: 10.1016/j.ejcb.2010.11.008 contributor: fullname: W Haeusgen – volume: 289 start-page: 4180 year: 2014 ident: 782_CR17 publication-title: J. Biol. Chem. doi: 10.1074/jbc.M113.530006 contributor: fullname: W Ouyang – volume: 336 start-page: 241 issue: Pt 1 year: 1998 ident: 782_CR28 publication-title: Biochem. J doi: 10.1042/bj3360241 contributor: fullname: M Shaw – volume: 107 start-page: 5471 year: 2010 ident: 782_CR32 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.0908899107 contributor: fullname: RB Chagpar – volume: 277 start-page: 19382 year: 2002 ident: 782_CR26 publication-title: J. Biol. Chem. doi: 10.1074/jbc.M200732200 contributor: fullname: CF Yu – volume: 99 start-page: 419 year: 2002 ident: 782_CR37 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.012581799 contributor: fullname: K Ueki – volume: 352 start-page: 739 issue: Pt 3 year: 2000 ident: 782_CR7 publication-title: Biochem. J. doi: 10.1042/bj3520739 contributor: fullname: G Vitale – volume: 8 start-page: 55863 year: 2017 ident: 782_CR30 publication-title: Oncotarget doi: 10.18632/oncotarget.19866 contributor: fullname: Y Ito – volume: 17 start-page: 297 year: 2016 ident: 782_CR43 publication-title: Pharmacogenomics doi: 10.2217/pgs.15.174 contributor: fullname: LW Cheung – volume: 1111 start-page: 189 year: 2019 ident: 782_CR5 publication-title: Adv. Exp. Med. Biol. doi: 10.1007/5584_2018_273 contributor: fullname: BE Turk – volume: 73 start-page: 8275 year: 2005 ident: 782_CR16 publication-title: Infect. Immun. doi: 10.1128/IAI.73.12.8275-8281.2005 contributor: fullname: JE Comer – volume: 9 year: 2008 ident: 782_CR12 publication-title: BMC Bioinformatics contributor: fullname: Y Zhang – volume: 42 start-page: 2995 year: 2003 ident: 782_CR29 publication-title: Biochemistry doi: 10.1021/bi0205911 contributor: fullname: S Qin – volume: 177 start-page: 325 year: 2019 ident: 782_CR47 publication-title: Breast Cancer Res. Treat. doi: 10.1007/s10549-019-05320-x contributor: fullname: SB Turturro – volume: 69 start-page: 185 year: 2015 ident: 782_CR2 publication-title: Annu. Rev. Microbiol. doi: 10.1146/annurev-micro-091014-104523 contributor: fullname: M Moayeri – volume: 278 start-page: 9402 year: 2003 ident: 782_CR8 publication-title: J. Biol. Chem. doi: 10.1074/jbc.M211262200 contributor: fullname: AP Chopra – volume: 248 start-page: 706 year: 1998 ident: 782_CR38 publication-title: Biochem. Biophys. Res. Commun. doi: 10.1006/bbrc.1998.9040 contributor: fullname: G Vitale – volume: 441 start-page: 23 year: 2012 ident: 782_CR3 publication-title: Biochem J. doi: 10.1042/BJ20111164 contributor: fullname: P Mellor – volume: 274 start-page: 12323 year: 1999 ident: 782_CR13 publication-title: J. Biol. Chem. doi: 10.1074/jbc.274.18.12323 contributor: fullname: AG Harpur – volume: 7 start-page: e49741 year: 2012 ident: 782_CR40 publication-title: PLoS ONE doi: 10.1371/journal.pone.0049741 contributor: fullname: KA Hellmich – volume: 18 start-page: 293 year: 2000 ident: 782_CR48 publication-title: Protein Expr. Purif. doi: 10.1006/prep.2000.1208 contributor: fullname: S Park – volume: 292 start-page: 17919 year: 2017 ident: 782_CR18 publication-title: J. Biol. Chem. doi: 10.1074/jbc.M117.805648 contributor: fullname: W Ouyang – volume: 30 start-page: 4567 year: 2011 ident: 782_CR27 publication-title: Oncogene doi: 10.1038/onc.2011.164 contributor: fullname: Y Lu – volume: 26 start-page: 379 year: 2000 ident: 782_CR34 publication-title: Nat. Genet. doi: 10.1038/81715 contributor: fullname: DA Fruman – volume: 107 start-page: 15547 year: 2010 ident: 782_CR46 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.1009652107 contributor: fullname: M Sun – volume: 11 start-page: 60 year: 2004 ident: 782_CR9 publication-title: Nat. Struct. Mol. Biol. doi: 10.1038/nsmb708 contributor: fullname: BE Turk – volume: 180 start-page: 4218 year: 2008 ident: 782_CR22 publication-title: J. Immunol. doi: 10.4049/jimmunol.180.6.4218 contributor: fullname: JP Luyendyk – volume: 283 start-page: 393 year: 1999 ident: 782_CR35 publication-title: Science doi: 10.1126/science.283.5400.393 contributor: fullname: DA Fruman – volume: 106 start-page: 20258 year: 2009 ident: 782_CR45 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.0902369106 contributor: fullname: H Wu – volume: 22 start-page: 317 year: 2014 ident: 782_CR1 publication-title: Trends Microbiol. doi: 10.1016/j.tim.2014.02.012 contributor: fullname: S Liu – volume: 287 start-page: 2632 year: 2012 ident: 782_CR21 publication-title: J. Biol. Chem. doi: 10.1074/jbc.M111.323709 contributor: fullname: A Gutierrez-Uzquiza – volume: 292 start-page: 814 year: 2017 ident: 782_CR15 publication-title: J. Biol. Chem. doi: 10.1074/jbc.M116.761734 contributor: fullname: AB Goldberg – volume: 8 start-page: e1002638 year: 2012 ident: 782_CR6 publication-title: PLoS Pathog. doi: 10.1371/journal.ppat.1002638 contributor: fullname: JL Levinsohn – volume: 16 start-page: 463 year: 2009 ident: 782_CR44 publication-title: Cancer Cell doi: 10.1016/j.ccr.2009.10.016 contributor: fullname: BS Jaiswal – volume: 4 start-page: e06866 year: 2015 ident: 782_CR14 publication-title: eLife doi: 10.7554/eLife.06866 contributor: fullname: LW Cheung – volume: 276 start-page: 30359 year: 2001 ident: 782_CR20 publication-title: J. Biol. Chem. doi: 10.1074/jbc.M009698200 contributor: fullname: JP Gratton – volume: 52 start-page: 5.8.1 year: 2015 ident: 782_CR10 publication-title: Curr. Protoc. Bioinformatics doi: 10.1002/0471250953.bi0508s52 contributor: fullname: J Yang – volume: 169 start-page: 381 year: 2017 ident: 782_CR23 publication-title: Cell doi: 10.1016/j.cell.2017.04.001 contributor: fullname: BD Manning – volume: 75 start-page: 100657 year: 2020 ident: 782_CR4 publication-title: Adv. Biol. Regul. doi: 10.1016/j.jbior.2019.100657 contributor: fullname: MK Rathinaswamy – volume: 2006 start-page: pe49 year: 2006 ident: 782_CR33 publication-title: Sci. STKE doi: 10.1126/stke.3622006pe49 contributor: fullname: DF Barber – volume: 72 start-page: 3228 year: 2012 ident: 782_CR24 publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-11-3747 contributor: fullname: AB Turke – volume: 113 start-page: E4079 year: 2016 ident: 782_CR42 publication-title: Proc. Natl Acad. Sci. USA contributor: fullname: S Liu – volume: 103 start-page: 12093 year: 2006 ident: 782_CR31 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.0604628103 contributor: fullname: CM Taniguchi – volume: 280 start-page: 734 year: 1998 ident: 782_CR39 publication-title: Science doi: 10.1126/science.280.5364.734 contributor: fullname: NS Duesbery – volume: 8 start-page: 197 year: 2016 ident: 782_CR41 publication-title: Toxins doi: 10.3390/toxins8070197 contributor: fullname: C Bachran – volume: 109 start-page: 141 year: 2002 ident: 782_CR36 publication-title: J. Clin. Invest. doi: 10.1172/JCI0213305 contributor: fullname: F Mauvais-Jarvis |
SSID | ssj0001626686 |
Score | 2.2482703 |
Snippet | Anthrax lethal toxin (LT), produced by
Bacillus anthracis
, comprises a receptor-binding moiety, protective antigen and the lethal factor (LF) protease
1
,
2
.... Anthrax lethal toxin (LT), produced by Bacillus anthracis, comprises a receptor-binding moiety, protective antigen and the lethal factor (LF) protease .... Anthrax lethal toxin (LT), produced by Bacillus anthracis, comprises a receptor-binding moiety, protective antigen and the lethal factor (LF) protease1,2.... |
SourceID | pubmedcentral proquest crossref pubmed springer |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 1464 |
SubjectTerms | 1-Phosphatidylinositol 3-kinase 101/1 13 13/106 42/70 45/41 631/326/421 631/326/88 692/699/1785 692/699/255 82 82/29 82/58 82/80 82/83 96/109 96/34 96/95 Amino Acid Motifs Animals Anthrax Anthrax - enzymology Anthrax - genetics Anthrax - microbiology Anthrax lethal toxin Antigens, Bacterial - metabolism Antigens, Bacterial - toxicity Bacillus anthracis - enzymology Bacillus anthracis - metabolism Bacterial Toxins - metabolism Bacterial Toxins - toxicity Biomedical and Life Sciences Class Ia Phosphatidylinositol 3-Kinase - chemistry Class Ia Phosphatidylinositol 3-Kinase - genetics Class Ia Phosphatidylinositol 3-Kinase - metabolism Homology Humans Infectious Diseases Inflammasomes Kinases Lethal factor Lethality Letter Life Sciences Male MAP kinase Medical Microbiology Mice Mice, Inbred C57BL Microbiology MKKS protein Parasitology Peptide Hydrolases - genetics Peptide Hydrolases - metabolism Phosphatidylinositol 3-Kinases - chemistry Phosphatidylinositol 3-Kinases - genetics Phosphatidylinositol 3-Kinases - metabolism Proline Protective antigen Protein kinase Regulatory subunits Signal transduction Virology |
Title | Anthrax lethal factor cleaves regulatory subunits of phosphoinositide-3 kinase to contribute to toxin lethality |
URI | https://link.springer.com/article/10.1038/s41564-020-0782-1 https://www.ncbi.nlm.nih.gov/pubmed/32895527 https://www.proquest.com/docview/2475051852 https://www.proquest.com/docview/2440905499 https://pubmed.ncbi.nlm.nih.gov/PMC11540063 |
Volume | 5 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fi9QwEB50F8EX8bfV84jgkxKuTbpt8iS3csshuIh4cG8laRJ2EZp125W7_95M2u6yHvrQh9KhbfIlmW8ykxmA98ooW6bMUVfIkubMWaqMLGguTKCvsmRpjQecvy6Ly6v8y_Xsethwa4ewynFNjAu18TXukZ-xPOi2GR71_bT5RbFqFHpXhxIa92HKMi7EBKbzi-W374ddlsDXC1GM7kwuzlq0WHKKVhNqR5odK6Q7LPNusORfHtOoiBaP4dHAIMl5D_kTuGebp_Cgryl5-wx8LH2gbkgAZBXk-oI6JIiq37Yl2772vN_eknand2FCt8Q7sln5NlzrJsZwGUs5-blugoYjnScxnB3rYsW7zt-sm-HtgcI_h6vFxY_Pl3SoqkDrYGp0NCsdm2GwCDO61jqVqSosZ9xYa3Va1twKleks1aW1jvGwHnCTMWW1MoHMFJK_gEnjG_sKSF4z7pgzs6zUueRSx_Tv3NUyr4VkOoEPY9dWmz55RhWd3lxUPQ5VwKFCHKosgZOx86thHrXVAfUE3u0fhxmAbg3VWL9DmWCjpmjnJvCyx2r_NR7sScwxl4A4QnEvgNm1j58061XMso15ipDAJfBxBPzwX_9sxev_t-INPGQ49GI8zAlMuu3Ovg2sptOnMD1fzOfL02EI_wEZd_s9 |
link.rule.ids | 230,314,780,784,885,21388,27924,27925,33744,33745,43805 |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwEB7BVgguiGdJKWAkTiCriZ2XTwhQqwXaFUKt1Ftkx7Z2hRQvm2zV_ns8TrKrpYJDDlFGSezP9nzjGc8AvJNamiJmltpcFDRl1lCpRU7TUnv6KgoW13jA-WyWTy_Sb5fZ5bDh1g5hleOaGBZq7WrcIz9iqddtGR71_bj8TbFqFHpXhxIad2EPM6dnE9j7fDz78XO7y-L5el7mozuTl0ctWiwpRasJtSNNdhXSLZZ5O1jyL49pUEQnj-DhwCDJpx7yx3DHNE_gXl9T8uYpuFD6QF4TD8jcy_UFdYgXlVemJau-9rxb3ZB2rdZ-QrfEWbKcu9ZfiybEcGlDOfm1aLyGI50jIZwd62KFu85dL5rh7Z7CP4OLk-PzL1M6VFWgtTc1OpoUlmUYLMK0qpWKRSxzwxnXxhgVFzU3pUxUEqvCGMu4Xw-4Tpg0SmpPZnLBn8OkcY15ASStGbfM6iwpVCq4UCH9O7e1SOtSMBXB-7Frq2WfPKMKTm9eVj0OlcehQhyqJILDsfOrYR611Rb1CN5uHvsZgG4N2Ri3Rhlvo8Zo50aw32O1-Rr39iTmmIug3EFxI4DZtXefNIt5yLKNeYqQwEXwYQR8-1__bMXB_1vxBu5Pz89Oq9Ovs-8v4QHDYRhiYw5h0q3W5pVnOJ16PQzjPxa-_Kk |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Anthrax+lethal+factor+cleaves+regulatory+subunits+of+phosphoinositide-3+kinase+to+contribute+to+toxin+lethality&rft.jtitle=Nature+microbiology&rft.au=Mendenhall%2C+Megan+A&rft.au=Liu%2C+Shihui&rft.au=Portley%2C+Makayla+K&rft.au=O%27Mard%2C+Danielle&rft.date=2020-12-01&rft.issn=2058-5276&rft.eissn=2058-5276&rft.volume=5&rft.issue=12&rft.spage=1464&rft_id=info:doi/10.1038%2Fs41564-020-0782-1&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2058-5276&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2058-5276&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2058-5276&client=summon |